BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 5354350)

  • 1. The effect of benzonal and benzamyl on the neurogenic (neurotic) experimental hypertension in dogs.
    Melnikov EA
    Cor Vasa; 1969; 11(2):122-7. PubMed ID: 5354350
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of benzonal and benzamyl on renal function in dogs with experimental hypertension].
    Pashinskiĭ VG
    Farmakol Toksikol; 1967; 30(1):71-4. PubMed ID: 5594363
    [No Abstract]   [Full Text] [Related]  

  • 3. Presynaptic dopamine receptor stimulation and the antihypertensive action of pergolide in experimental neurogenic hypertension.
    Barrett RJ; Lokhandwala MF
    Proc West Pharmacol Soc; 1982; 25():39-42. PubMed ID: 7122527
    [No Abstract]   [Full Text] [Related]  

  • 4. [Absence of the effect of nitric oxide on pulmonary and systemic hypertension induced by sino-aortic denervation].
    Galinier M; Rougé P; Albenque JP; Assoun B; Massabuau P; Fauvel JM; Bounhoure JP; Montastruc JL; Montastruc P
    Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1209-12. PubMed ID: 8572875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of benzonal on several adverse effects of cystamine].
    Smirnova SM; Iusipov VS; Zaĭtseva TG
    Farmakol Toksikol; 1975; 38(1):86-8. PubMed ID: 1112402
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of adrenolytic drugs on the antihypertensive action of beta-blocking agents in the acute neurogenic hypertensive dog.
    Montastruc JL; Morales-Olivas F; Montastruc P
    J Pharmacol; 1981; 12(4):427-39. PubMed ID: 7321572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the adrenal medulla in the antihypertensive action of bromocriptine in neurogenic hypertensive dogs.
    Montastruc JL; Montastruc P
    J Pharmacol; 1983; 14(2):183-7. PubMed ID: 6865444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Possibility of producing experimental neurotic hypertonia in dogs].
    Grüner M; Nitschkoff S
    Acta Biol Med Ger; 1970; 24(5):593-602. PubMed ID: 5534771
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 3rd communication: antihypertensive effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2, 3-b] pyridine-5-carboxylate in hypertensive rats and dogs.
    Ueda M; Matsumura S; Masui M; Matsuura E; Kawakami M; Fujitomo H; Umeda T; Kagawa H; Hirohata S; Shima K
    Arzneimittelforschung; 1993 Dec; 43(12):1282-90. PubMed ID: 8141815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naloxone and acute neurogenic hypertension in anaesthetized dogs.
    Montastruc JL; Montastruc P
    Arch Farmacol Toxicol; 1982 Apr; 8(1):45-8. PubMed ID: 7138086
    [No Abstract]   [Full Text] [Related]  

  • 11. [Influence of nephrectomy on the antihypertensive effects of propranolol in the dog (author's transl)].
    Montastruc JL; Gaillard-Plaza G; Thomas J; Montastruc P
    J Pharmacol; 1981; 12(4):465-70. PubMed ID: 7321575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental central neurogenic hypertension from brainstem dysfunction: evidence for a central neural imbalance hypothesis of hypertension.
    Reis DJ
    Res Publ Assoc Res Nerv Ment Dis; 1981; 59():229-57. PubMed ID: 6109366
    [No Abstract]   [Full Text] [Related]  

  • 13. Antihypertensive activity of N-[(S)-1-(ethoxycarbonyl)-3-phenylpropyl]-L-Ala-L-Pro (MK-421), an orally active converting enzyme inhibitor.
    Sweet CS; Gross DM; Arbegast PT; Gaul SL; Britt PM; Ludden CT; Weitz D; Stone CA
    J Pharmacol Exp Ther; 1981 Mar; 216(3):558-66. PubMed ID: 6259323
    [No Abstract]   [Full Text] [Related]  

  • 14. [Results of the therapeutic management of pregnancy toxemia].
    López-Llera M; Alvarado A; Ray Lara J; Torres Del Toro B
    Ginecol Obstet Mex; 1965; 20(117):623-30. PubMed ID: 5863737
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiovascular effects of a new antihypertensive agent in several species.
    Salvati P; Caravaggi AM; Lamberti E; Monteggia M; Bianchi G
    Arzneimittelforschung; 1983; 33(8):1098-106. PubMed ID: 6685486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Central effect of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride].
    Hukuhara T; Otsuka Y; Takeda R; Sukai F
    Arzneimittelforschung; 1968 Sep; 18(9):1147-53. PubMed ID: 5755929
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the efficacy of onosma in experimental hypertension].
    Larin AP; Aleutskiĭ NN
    Farmakol Toksikol; 1967; 30(6):694-6. PubMed ID: 5598439
    [No Abstract]   [Full Text] [Related]  

  • 18. [A new hypotensive agent with central action].
    Fritel D
    Therapeutique; 1970 Nov; 46(9):893-5. PubMed ID: 5486137
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of benzonal on the resistance of animals to the action of organophosphorus and carbamic compounds].
    Kagan IuS; Kokshareva NV; Savateev NV; Liniuchev MN; Sergeev VV
    Farmakol Toksikol; 1983; 46(5):100-3. PubMed ID: 6628651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on the effect of dichlorphenylaminoimidazoline (Haemiton) in arterial hypertension].
    Thiel H; Mitschke H
    Dtsch Gesundheitsw; 1970 Nov; 25(45):2109-15. PubMed ID: 5487971
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.